Your browser doesn't support javascript.
loading
A Comparison of Ramipril and Bevacizumab to Mitigate Radiation-Induced Brain Necrosis: An Experimental Study.
Erpolat, Ozge Petek; Demircan, Niyazi Volkan; Saribas, Gulistan Sanem; Kuzucu, Pelin; Senturk, Ertugrul; Elmas, Cigdem; Borcek, Alp; Kurt, Gokhan.
Afiliação
  • Erpolat OP; Department of Radiation Oncology, Gazi University Medical Faculty, Ankara, Turkey.
  • Demircan NV; Department of Radiation Oncology, Gazi University Medical Faculty, Ankara, Turkey. Electronic address: nvdemircan@gmail.com.
  • Saribas GS; Department of Histology, Ahi Evran University Medical Faculty, Kirsehir, Turkey.
  • Kuzucu P; Department of Neurosurgery, Gazi University Medical Faculty, Ankara, Turkey.
  • Senturk E; Department of Radiation Oncology, Gazi University Medical Faculty, Ankara, Turkey.
  • Elmas C; Department of Histology, Gazi University Medical Faculty, Ankara, Turkey.
  • Borcek A; Department of Neurosurgery, Gazi University Medical Faculty, Ankara, Turkey.
  • Kurt G; Department of Neurosurgery, Gazi University Medical Faculty, Ankara, Turkey.
World Neurosurg ; 144: e210-e220, 2020 12.
Article em En | MEDLINE | ID: mdl-32822951

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões Experimentais por Radiação / Encéfalo / Inibidores da Enzima Conversora de Angiotensina / Radiocirurgia / Ramipril / Inibidores da Angiogênese / Bevacizumab Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões Experimentais por Radiação / Encéfalo / Inibidores da Enzima Conversora de Angiotensina / Radiocirurgia / Ramipril / Inibidores da Angiogênese / Bevacizumab Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article